Zi-Chang Liu
Overview
Explore the profile of Zi-Chang Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
7
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di S, Chen W, Yang W, Zhang X, Dong K, Tian Y, et al.
Cell Death Dis
. 2024 Jul;
15(7):533.
PMID: 39068164
Renal cell carcinoma (RCC) is considered a "metabolic disease" characterized by elevated glycolysis in patients with advanced RCC. Tyrosine kinase inhibitor (TKI) therapy is currently an important treatment option for...
2.
Wang Y, Chen W, Zhou W, Dong K, Zuo L, Xu D, et al.
J Immunother Cancer
. 2024 Jun;
12(6).
PMID: 38908856
Background: Tertiary lymphoid structures (TLSs) serve as organized lymphoid aggregates that influence immune responses within the tumor microenvironment. This study aims to investigate the characteristics and clinical significance of TLSs...
3.
Chen W, Pan X, Song X, Liu Z, Xu D, Chen J, et al.
Cancer Lett
. 2024 May;
593:216963.
PMID: 38768682
Neoadjuvant tyrosine kinase inhibitor (TKI) therapy is an important treatment option for advanced renal cell carcinoma (RCC). Many RCC patients may fail to respond or be resistant to TKI therapy....